'Explanation not enough': Union health minister asks Ramdev to withdraw statement on allopathic medicinesIn a strongly worded letter to Ramdev, the minister also said that "through your statement you not only disrespected corona warriors but al...
UP government orders 50 lakh doses of Covisheild, Covaxin eachSo far, 1,17,77,209 vaccine doses have been given in the state. This includes 97,79,846 first doses and 19,97,363 second doses, the stateme...
Pakistan approves emergency use of third Chinese COVID-19 vaccine despite low efficacy rateThe Drug Regulatory Authority of Pakistan (DRAP) on Thursday granted Emergency Use Authorisation (EUA) to CoronaVac, developed by Chinese c...
Pakistan approves emergency use of third Chinese COVID vaccine, despite its low efficacy rateCiting officials, Geo News reported that the Drug Regulatory Authority of Pakistan (DRAP) has granted Emergency Use Authorization (EUA) to ...
ChrysCap to buy 30% in Corona Remedies for Rs 670 croreChrysCap has signed a deal to acquire 20% stake from PE firm Creador, which is an existing investor, and another 10% from promoters, two pe...
China approves second domestic Covid-19 vaccineThe vaccine has already been rolled out to key groups at higher risk of exposure to coronavirus but Saturday's approval allows for its use ...
Once vaccine comes, COVID-19 will go away: AthawaleA vaccine against COVID-19 will be introduced in the country in next one or two months, he said.
Brazil drug agency questions 'transparency' of China vaccineThe Brazilian health regulator Anvisa on Monday accused China of using criteria that "are not transparent" to win emergency approval of its...
Halted Brazil trials of Chinese-made coronavirus vaccine cause surpriseThe potential vaccine is being developed by Chinese biopharmaceutical firm Sinovac and in Brazil would be mostly produced by Sao Paulo's st...
PE fund Creador to sell Corona Remedies stake; eyes Rs 2,400 cr valuationSpark Capital is advising the PE fund for the stake sale. The proposed deal is expected to value Corona at Rs.2000-2400 crore.
SC seeks Centre's reply on plea alleging no approval for Remdesivir, Favipiravir to treat COVID-19A bench led by CJI S.A. Bobde issued notices to the central government on a petition filed by lawyer Manoharlal Sharma claiming that these ...
Bharat Biotech starts human trial of its anti-COVID vaccine at PGI Rohtak: Minister Vij“Human trial with Corona vaccine (COVAXIN) of Bharat Biotech started at PGI Rohtak today,” Vij, who is also the Home and Science & Technolo...
Bayer partners with Maharashtra government to set up 100-bed corona care facility in AurangabadOver the last few months, Bayer has been collaborating with Maharashtra government, local officials and other organisations in the fight ag...
Didn't promote COVID-19 cure, just shared trial results: PatanjaliThe claim triggered a row with the Union AYUSH ministry telling the herbal products firm not to sell the drug till it has examined the issu...
CCI approves Corona Remedies-GlaxoSmithKline dealDilo-BM, Dilo-DX, Stelbid and Vitneurin brands of GlaxoSmithKline would be acquired by Corona Remedies along with trademark and goodwill.
Creador Capital close to investing Rs 118 crore for minority stake in Corona RemediesAccording to people close to the development, Creador will be picking up about 20% stake in Corona, valuing the company at around Rs 500 cr...
Corona inks agreement with Kitozyme for a fat binder anti-obesity drugBelgium life science company, Kitozyme entered into in-licensing agreement with Corona Remedies for fat binder anti-obesity drug.